Interleukin-32α expression in human colonic subepithelial myofibroblasts

Int J Mol Med. 2011 Feb;27(2):263-8. doi: 10.3892/ijmm.2010.575. Epub 2010 Dec 6.

Abstract

Interleukin (IL)-32 is a recently described proinflammatory cytokine, characterized by induction of nuclear factor (NF)-κB activation. We studied IL-32α expression in human colonic subepithelial myofibroblasts (SEMFs). Colonic SEMFs were isolated from normal human colon tissue. IL-32α protein expression was evaluated by Western blot analyses, and IL-32α mRNA expression was analyzed by real-time PCR. IL-32α mRNA was weakly expressed without a stimulus, and its expression was markedly enhanced by IL-1ß and TNF-α. IL-1ß and TNF-α enhanced intracellular accumulation of IL-32α protein, but IL-32α was not detected in supernatants. Each cytokine dose- and time-dependently induced IL-32α mRNA expression. An inhibitor of phosphatidylinositol 3-kinase (LY294002) significantly suppressed IL-1ß- and TNF-α-induced IL-32α mRNA expression, although MAPK inhibitors had no effect. Akt activation in response to these cytokines was confirmed by Western blotting. Blockade of NF-κB activation by an adenovirus expressing a stable mutant form of IκBα markedly suppressed IL-1ß- and TNF-α-induced IL-32α mRNA expression. Human colonic SEMFs expressed IL-32α in response to IL-1ß and TNF-α. IL-32α mRNA expression depends on the phosphatidylinositol 3-kinase and the NF-κB system.

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Cell Line
  • Cells, Cultured
  • Colon / cytology
  • Enzyme Induction / drug effects
  • Gene Expression Regulation, Enzymologic* / drug effects
  • Humans
  • Interleukin-1beta / pharmacology
  • Interleukins / genetics
  • Interleukins / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism
  • Myofibroblasts / drug effects
  • Myofibroblasts / metabolism*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Phosphatidylinositol 3-Kinase / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism
  • Proto-Oncogene Proteins c-jun / genetics
  • Proto-Oncogene Proteins c-jun / metabolism
  • Signal Transduction / drug effects
  • Transcription Factor AP-1 / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Adjuvants, Immunologic
  • IL32 protein, human
  • Interleukin-1beta
  • Interleukins
  • NF-kappa B
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-jun
  • Transcription Factor AP-1
  • Tumor Necrosis Factor-alpha
  • Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases